Durable complete response with PANVAC and Trastuzumab in metastatic triple positive breast cancer (mTPBC)

被引：0
|
作者：
Gatti-Mays, Margaret [1 ]
Mohebtash, Mahsa [2 ]
Madan, Ravi [1 ]
Strauss, Julius [1 ]
Bilusic, Marijo [1 ]
Jochems, Caroline [1 ]
Rauckhorst, Myrna [1 ]
Jones, Elizabeth [3 ]
Dahut, William [1 ]
Schlom, Jeffrey [1 ]
Gulley, James [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Medstar Union Mem Hosp, Baltimore, MD USA
[3] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P440
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Trastuzumab in metastatic breast cancer after complete remission: How long is enough?
    Oguz, Arzu
    Rahatli, Samed
    Altundag, Ozden
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2015, 32 (08)
  • [32] Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
    Kadri Altundag
    Breast Cancer Research and Treatment, 2018, 167 : 815 - 815
  • [33] Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 815 - 815
  • [34] Complete response after pertuzumab plus trastuzumab plus docetaxel in metastatic Her2-positive breast cancer patients: review of four cases
    Lai-Tiong, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 845 - 846
  • [35] A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer
    Hideo Shigematsu
    Takayuki Kadoya
    Yoshie Kobayashi
    Keiko Kajitani
    Tatsunari Sasada
    Akiko Emi
    Norio Masumoto
    Rumi Haruta
    Tsuyoshi Kataoka
    Miyo Oda
    Kouji Arihiro
    Morihito Okada
    World Journal of Surgical Oncology, 9
  • [36] A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer
    Shigematsu, Hideo
    Kadoya, Takayuki
    Kobayashi, Yoshie
    Kajitani, Keiko
    Sasada, Tatsunari
    Emi, Akiko
    Masumoto, Norio
    Haruta, Rumi
    Kataoka, Tsuyoshi
    Oda, Miyo
    Arihiro, Kouji
    Okada, Morihito
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
  • [37] Complete Durable Response From Carboplatin and Olaparib in a Heavily Pretreated Triple-Negative Metastatic Breast Cancer With Germline BRCA2 and "BRCAness" Mutations
    Hong, Sanghee
    Funchain, Pauline
    Haddad, Abdo
    Crowe, Joseph
    Dalpiaz, Nancy
    Abraham, Jame
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (03) : 270 - +
  • [38] Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer
    Andrew D. Seidman
    Larry Norton
    Current Oncology Reports, 2005, 7 (1) : 9 - 11
  • [39] Subcutaneous trastuzumab in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (01)
  • [40] Trastuzumab and capecitabine for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1039): : 106 - 108
12345